EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $366,006 | -62.3% | 23,209 | -30.2% | 0.01% | -64.3% |
| Q4 2022 | $972,102 | +14.1% | 33,257 | +3.1% | 0.03% | 0.0% |
| Q3 2022 | $852,000 | -37.6% | 32,245 | +4.9% | 0.03% | -30.0% |
| Q2 2022 | $1,366,000 | -7.5% | 30,746 | +3.1% | 0.04% | +33.3% |
| Q1 2022 | $1,476,000 | +50.6% | 29,834 | +30.3% | 0.03% | -3.2% |
| Q2 2021 | $980,000 | +13.3% | 22,897 | +10.5% | 0.03% | -3.1% |
| Q1 2021 | $865,000 | +31.3% | 20,727 | +46.4% | 0.03% | +3.2% |
| Q4 2020 | $659,000 | +21.4% | 14,154 | +10.7% | 0.03% | 0.0% |
| Q3 2020 | $543,000 | +99.6% | 12,786 | +125.4% | 0.03% | -31.1% |
| Q2 2020 | $272,000 | – | 5,673 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |